COVID-19大流行期间泌尿外科标准诊疗指南与推荐的系统评价
该研究系统检索2019年11月至2020年4月17日间发表的指南与推荐,最终纳入15部国际泌尿外科组织或参考中心的指南,按PRISMA进行系统评价。14部指南涉及急诊情况,12部涉及择期泌尿肿瘤评估,共识为除高危前列腺癌外推迟根治性前列腺切除术,低级别膀胱癌、小肾mass(达T2)和I期精原细胞瘤延迟治疗。9部涉及腔内泌尿外科的指南认为梗阻或感染肾应减压,非梗阻结石和支架取出应重新安排。所有推荐均为专家意见,仅欧洲泌尿外科学会指南提供循证证据等级(多为3级证据)。
要点
- 15部指南中14部涉及急诊情况,12部涉及择期泌尿肿瘤评估,共识为除高危前列腺癌外推迟根治性前列腺切除术。
- 低级别膀胱癌、小肾mass(达T2)和I期精原细胞瘤应延迟治疗(多数指南共识)。
- 9部腔内泌尿外科指南认为梗阻或感染肾应减压,非梗阻结石和支架取出应重新安排。
- 5部指南/推荐讨论腹腔镜和机器人手术,其余关注门诊操作和咨询。
- 所有推荐均为专家意见,仅欧洲泌尿外科学会指南提供循证证据等级(多为3级证据)。
适用人群与场景
- COVID-19大流行期间需要泌尿外科诊疗的患者,涵盖急诊情况、择期泌尿肿瘤手术、腔内泌尿外科、腹腔镜和机器人手术、门诊操作和咨询。
处置流程与药物剂量
- 除高危前列腺癌外,推迟根治性前列腺切除术(多数指南共识)。
- 低级别膀胱癌、小肾mass(达T2)和I期精原细胞瘤延迟治疗(多数指南共识)。
- 梗阻或感染肾应减压,非梗阻结石和支架取出应重新安排(9部腔内泌尿外科指南)。
研究设计与关键结果
- 系统评价纳入15部指南,其中14部涉及急诊情况,12部涉及择期泌尿肿瘤评估。
- 共识为除高危前列腺癌外推迟根治性前列腺切除术,低级别膀胱癌、小肾mass(达T2)和I期精原细胞瘤延迟治疗。
- 9部腔内泌尿外科指南认为梗阻或感染肾应减压,非梗阻结石和支架取出应重新安排。
- 5部指南/推荐讨论腹腔镜和机器人手术,其余关注门诊操作和咨询。
- 所有推荐均为专家意见,3部由专业学会特别背书,仅欧洲泌尿外科学会指南提供循证证据等级(多为3级证据)。
证据类型、等级与局限
- 证据类型:系统评价(PRISMA),纳入15部指南/推荐。
- 所有推荐均为专家意见,仅欧洲泌尿外科学会指南提供循证证据等级(多为3级证据)。
- 局限:原文未报告局限性
对床旁实践的改变
- 大流行期间可依据多数指南共识,对非高危前列腺癌患者推迟根治性前列腺切除术,对低级别膀胱癌、小肾mass(达T2)和I期精原细胞瘤延迟治疗。
- 对梗阻或感染肾应减压,非梗阻结石和支架取出应重新安排。
- 各指南间差异极小,但推荐多为专家意见,仅欧洲泌尿外科学会指南提供证据等级。
指南或共识出处
- 纳入的15部国际泌尿外科组织或参考中心的指南与推荐(2019年11月至2020年4月17日发表),包括欧洲泌尿外科学会指南。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
CONTEXT: The first case of the new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), was identified in Wuhan, China, in late 2019. Since then, the coronavirus disease 2019 (COVID-19) outbreak was reclassified as a pandemic, and health systems around the world have faced an unprecedented challenge.
OBJECTIVE: To summarize guidelines and recommendations on the urology standard of care during the COVID-19 pandemic.
EVIDENCE ACQUISITION: Guidelines and recommendations published between November 2019 and April 17, 2020 were retrieved using MEDLINE, EMBASE, and CINAHL. This was supplemented by searching the web pages of international urology societies. Our inclusion criteria were guidelines, recommendations, or best practice statements by international urology organizations and reference centers about urological care in different phases of the COVID-19 pandemic. Our systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement. Of 366 titles identified, 15 guidelines met our criteria.
EVIDENCE SYNTHESIS: Of the 15 guidelines, 14 addressed emergency situations and 12 reported on assessment of elective uro-oncology procedures. There was consensus on postponing radical prostatectomy except for high-risk prostate cancer, and delaying treatment for low-grade bladder cancer, small renal masses up to T2, and stage I seminoma. According to nine guidelines that addressed endourology, obstructed or infected kidneys should be decompressed, whereas nonobstructing stones and stent removal should be rescheduled. Five guidelines/recommendations discussed laparoscopic and robotic surgery, while the remaining recommendations focused on outpatient procedures and consultations. All recommendations represented expert opinions, with three specifically endorsed by professional societies. Only the European Association of Urology guidelines provided evidence-based levels of evidence (mostly level 3 evidence).
CONCLUSIONS: To make informed decisions during the COVID-19 pandemic, there are multiple national and international guidelines and recommendations for urologists to prioritize the provision of care. Differences among the guidelines were minimal.
PATIENT SUMMARY: We performed a systematic review of published recommendations on urological practice during the coronavirus disease 2019 (COVID-19) pandemic, which provide guidance on prioritizing the timing for different types of urological care.
参考来源
- Heldwein FL, Loeb S, Wroclawski ML, et al. A Systematic Review on Guidelines and Recommendations for Urology Standard of Care During the COVID-19 Pandemic. Eur Urol Focus. 2020. PMID: 32532703. doi:10.1016/j.euf.2020.05.020
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。